Tebra CEO Recognized for Leadership and Organizational Effectiveness
IRVINE, Calif.–(BUSINESS WIRE)–#EHR—Tebra, a leader in practice growth technology and cloud-based clinical and financial software, today announced that its Chief Executive Officer, Dan Rodrigues, was named in The Healthcare Technology Report’s list of Top 50 Healthcare Technology CEOs of 2022. The annual list recognizes the most accomplished executives in healthcare technology.
This year’s list comprises a broad range of CEOs with a diverse set of backgrounds, all of whom make a profound impact on moving healthcare toward the future. An extensive process was run to evaluate the hundreds of CEOs who were nominated this year. Read the full report here.
Under Rodrigues’ direction and leadership, Tebra has over 1,000 employees dedicated to helping more than 100,000 healthcare providers run more efficient and profitable practices while delivering outstanding patient care and a modern healthcare experience to more than 80 million patients in the United States.
“I am honored to be chosen as a healthcare technology leader amongst the other exemplary nominations,” Rodrigues said. “The recognition also highlights the commitment and work that the entire team at Tebra accomplishes every day to deliver digital tools that help providers deliver modernized care to patients.”
About Tebra
In 2021, with a combined mission to unlock better healthcare, Kareo and PatientPop joined forces to form Tebra — the operating system for the connected practice of the future. With an all-in-one, purpose-built platform to drive practice success and modernize every step of the patient journey, Tebra provides digital tools and support to attract new patients, deliver modern care, get paid quickly, and operate their practice efficiently. To learn more how Tebra is committed to improving the success and well-being of both patients and providers, visit www.tebra.com.
Contacts
Amanda Feld
Tebra
(310) 968-6831
Amanda.feld@kareo.com
THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE (7)(1) OF THE EUROPEAN…
BOUCHERVILLE, Québec, June 28, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC. (TSXV: LSL, LSL.DB)…
SALINAS, Calif., June 28, 2024 (GLOBE NEWSWIRE) -- Lowell Farms Inc. (the “Company”) (CSE: LOWL;…
MINNEAPOLIS, MN, US, June 28, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTC: PETV, PETVW),…
BETHESDA, Md., June 28, 2024 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or…
NEW YORK, June 28, 2024 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS; Nasdaq: CLLS), a…